Safety and Accuracy of Alveoscopy in Interstitial Lung Diseases
ALVEOLE
Phase II Study of Broncho-Alveoscopy Using Fibered Confocal Fluorescence Microscopy
2 other identifiers
observational
270
1 country
1
Brief Summary
Fibered confocal fluorescence microscopy (FCFM), also referred to as Cell-Vizio® (MaunaKea Technologies, France) is a new technique that produces microscopic imaging in a living tissue, through a 1 mm fiberoptic miniprobe that can be introduced into the working channel of the bronchoscope. The system produces real-time imaging of endogenous fluorophores with a 5 µm lateral resolution and a field of view of 600 x 600 µm. FCFM is able to produce dynamic, high-resolution microimaging of the respiratory bronchiolar walls, alveolar ducts and sacs in vivo during endoscopy (a procedure termed as alveoscopy). The hypothesis of this study is that an alveoscopy makes it possible to analyze the microstructure of the distal airways in vivo and to collect specific morphologic information in patients with interstitial lung diseases. The goals of this French Phase II trial are:
- to evaluate the tolerance of the alveoscopy
- to describe the normal appearance of the bronchoalveolar system in spontaneous ventilation in normal subjects
- to describe specific alterations of the bronchoalveolar microstructure in focal or diffuse interstitial lung diseases
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2006
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2006
CompletedFirst Submitted
Initial submission to the registry
September 15, 2006
CompletedFirst Posted
Study publicly available on registry
September 18, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedJuly 30, 2013
July 1, 2013
7.1 years
September 15, 2006
July 29, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
number of lesions localized by confocal endoscopy compared to navigational bronchoscopy
time of the confocal endoscopy compared to navigational bronchoscopy
Positive and negative predictive values of confocal signs before and after IV fluorophore injection for the diagnosis of cancer.
before and after IV fluorophore injection for the diagnosis of cancer.
Eligibility Criteria
Healthy smoker and non-smoker subjects, patients with no peripheral lung disease on CT scan, Patients with focal parenchymal lung diseases, patients with diffuse parenchymal lung diseases
You may qualify if:
- Healthy volunteers: normal chest X-rays and normal lung function tests
- Patients without parenchymal lung diseases: normal chest computed tomography (CT) scan, normal lung function tests, indication for a bronchoscopy
- Patients with parenchymal lung disease: indication for a bronchoscopy
- Written informed consent for the alveoscopy
You may not qualify if:
- Bleeding disorders
- Pulmonary hypertension
- Contraindication for a bronchoscopy
- known hypersensitivity to the fluorescent contrast agent (if required)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rouen University Hospital
Rouen, Haute Normandie, 76000, France
Related Publications (1)
Salaun M, Guisier F, Dominique S, Genevois A, Jounieaux V, Bergot E, Thill C, Piton N, Thiberville L. In vivo probe-based confocal laser endomicroscopy in chronic interstitial lung diseases: Specific descriptors and correlation with chest CT. Respirology. 2019 Aug;24(8):783-791. doi: 10.1111/resp.13507. Epub 2019 Feb 27.
PMID: 30811085DERIVED
Biospecimen
distal lung biopsy if of tumoral nature (fixed or frozen sample)
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Luc C Thiberville, MD
University Hospital, Rouen
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 15, 2006
First Posted
September 18, 2006
Study Start
May 1, 2006
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
July 30, 2013
Record last verified: 2013-07